Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Infectio
Print version ISSN 0123-9392
Abstract
CARDENAS, Lorena Liseth; MERCHAN, Maritza Angarita and LOPEZ, Diana Paola. New antibiotics against bacterial resistance. Infect. [online]. 2019, vol.23, n.4, pp.382-387. ISSN 0123-9392. https://doi.org/10.22354/in.v23i4.807.
The evolution of bacterial resistance is generating a serious public health problem due to the indiscriminate use of antibiotics, the application of non-optimal doses, the irregularity in the taking of medicines sent by the health professional, factors that have affected the increase in the rate of antimicrobial resistance; It is important to generate strategies that contribute to diminishing it, including the rational use of antibiotics and the constant research of new therapeutic alternatives such as teixobactin, which is a product of the Gram negative bacterium called Eleftheria terrae, related to the genus Aquabacterium, is a microorganism that presents extremophile conditions, for which, a multichannel system of semipermeable membranes called Ichip was developed for its isolation. Eravacycline is a new fully synthetic bacteriostatic antibiotic of the tetracycline family, is a potent inhibitor based on the mechanism of the bacterial ribosome and exerts potent activity against a broad spectrum of susceptible and multiresistant bacteria.
Keywords : teixobactin; eravacycline; tetracycline; bacterial resistance; lipid II; Eleftheria Terrae; Ichip.